Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Beta Bionics, Inc.NASDAQ: BBNX
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 25.0% from a year ago
Common stock stood at $5K at the end of Q1 FY2026, up 25.0% from a year earlier and up 25.0% from the prior quarter. Over 3 fiscal years it compounded at +58.7% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +25.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 4K USD
- Year-over-year change
- +300.0%
- 3-year CAGR
- +58.7%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4K | +300.0% |
| FY2024 | 2024-12-31 | 1K | +0.0% |
| FY2023 | 2023-12-31 | 1K | +0.0% |
| FY2022 | 2022-12-31 | 1K | — |
Common Stock vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +25.0% is the highest of 7, against a peer median of +0.0%.
- Common stock amounts to 0.0% of total assets for BBNX, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 446M DKK | +0.0% | -0.7% | 0.1% | |
| Mar 2026 | $3.09M USD | +1.6% | +5.3% | 0.4% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $3M USD | — | — | 0.1% |
| Mar 2026 | $491K USD | +0.0% | -0.3% | 0.2% | |
| Jun 2026 | $400K USD | +0.0% | +0.0% | 0.0% | |
| Jun 2026 | $100K USD | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $69K USD | +3.0% | +1.5% | 0.0% | |
| Mar 2026 | $5K USD | +25.0% | +58.7% | 0.0% | |
| Peer median (excluding BBNX) | — | +0.0% | +0.0% | 0.1% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.